Category Archives: ORA

NIH Provides Updated Definition of Clinical Trial

***IMPORTANT: NIH CLINICAL TRIAL FUNDING OPPORTUNITY ANNOUNCEMENT and UPDATED DEFINITION OF CLINICAL TRIAL*** The NIH Clinical Trial Funding Opportunity Announcement policy requires all applications with due dates on/after January 25, 2018 involving clinical trials be submitted through a FOA specific to clinical trials. More information on this will be provided by ORA over the upcoming […]

Also posted in Announcements, NIH | Tagged , , , | Comments closed

Alissa Bowman Joins ORA

  We are very pleased to welcome Alissa Bowman to the Office of Research Administration. Alissa joined ORA on August 14 in the role of Senior Instructional Designer. Alissa comes to Emory with a Bachelor of Science in Biology from University of North Carolina, Chapel Hill and a Master of Education in Curriculum from Arizona […]

Also posted in Announcements, RAE | Comments closed

FY17 Research Awards Received by Emory Grows to $628m Reflecting an Increase of Over 9%

Preliminary numbers for awards received by Emory University in FY17 is $628,021,369.  The final numbers are under review (changes, if any, will be minimal). This reflects an increase of 9.3% from FY16, an increase of over 20% in the most recent three years, and an almost 53% increase in research funding over the past ten […]

Also posted in Announcements | Tagged , , | Comments closed

Upcoming NCURA Webinars Hosted by OSP

  EFFORT REPORTING Thursday, June 1: 2:00-3:30 pm EDT — Room 5C Registration opens April 26 Featuring: Lisa Mosley, Arizona State University; Jeremy Forsberg, The University of Texas at Arlington; David Ngo, The New School; Jayne Goby, University of Illinois at Urbana-Champaign; Linda Gregory, University of Illinois   DATA SECURITY Thursday, June 15: 2:00-3:30 pm […]

Also posted in Announcements, IRB, NCURA, OSP | Tagged , , , , , | Comments closed

Ashley Myers’ new role as ORA’s Training and Communications Specialist

    Ashley Myers has been with Emory for over 6 years as a Program Coordinator for the Office of Research Administration. She has been a tremendous asset to Emory’s Office of Research Administration handling a broad area of responsibilities.  Recently, Ashley has accepted an offer to become ORA’s Training and Communication Specialist. In this role, Ashley […]

Also posted in Announcements, ORA - BO, ORA Spotlight, Training | Comments closed

Impact of FLSA Changes on NIH Funded Post Docs

NIH has issued guidance on projected FY2017 stipend levels for Postdoctoral Trainees and Fellows on Ruth L. Kirschstein National Research Service Awards (NRSA).  NIH’s plan is to raise the minimum NRSA compensation level to above the new Department of Labor (DOL) threshold of $47,476 which becomes effective December 1, 2016 (for exemption from overtime rules). […]

Also posted in OSP | Tagged , , | Comments closed

FY17 Federal Fringe Rates Available Now!

We have received approval for our FY17 federal fringe rates from DHHS.  The table below represents the university’s finalized fringe benefit rates for fiscal year 2017. For any proposals already created and in routing, if prepared with the old rate, the proposal may be submitted with old rate if the deadline is approaching. Departments, schools, […]

Also posted in Cost Studies, OSP | Tagged , , | Comments closed

Significant Emory HIPAA Policy Changes: Effective September 1, 2016

As previously announced, significant Emory HIPAA policy changes were to be effective pending changes to the HIPAA sections of our electronic IRB submission system.  The testing is concluded, and the effective date of the updated HIPAA policy will be September 1, 2016.  All studies created on or after this date will fall under the updated […]

Also posted in Announcements, Audit, IRB, OSP | Tagged | Comments closed

Eligibility Screening Questions May Require Informed Consent and/or HIPAA Authorization

Whether done over the phone, online, or in person, collecting identifiable private information for study screening purposes requires informed consent (and HIPAA authorization, if applicable). This consent/authorization can be much shorter than for the form for the study itself and the IRB can waive the requirement for a signature, if needed. The IRB has a […]

Also posted in IRB | Tagged | Comments closed

Requests to rely on Central IRBs

Emory looks at several considerations when deciding if we can cede review to an external IRB. Currently we rely on one commercial IRB – Western IRB or WIRB – for industry-sponsored Phase IIb-IV drug/device studies. We will not rely on any other commercial IRBs. We often enter into study-specific reliance agreements when the relying institution’s […]

Also posted in IRB | Tagged | Comments closed